Singleplex Immunoassay Market Size was valued at USD 0.186 Billion in 2023. The Global Singleplex Immunoassay industry is projected to grow from USD 0.197 Billion in 2024 to USD 0.207 Billion by 2032, exhibiting a compound annual growth rate (CAGR) of 10.34% during the forecast period (2024 - 2032).
Singleplex immunoassays such as Enzyme-Linked Immunosorbent Assays (ELISA) or western blotting are used sequentially to analyze multiple intracellular and extracellular proteins. Moreover, singleplex immunoassay provides a fast and high-through output solution for gene expression quantification. For instance, , application, and end-user.
On the basis of the product and services, the market is classified as consumables, instruments, and others.
The global singleplex immunoassay market on the basis of the type is segmented as protein-based assays, nucleic acid-based assays, cell-based assays, and others.
On the basis of technology, the market is segmented into flow cytometry, fluorescence detection, and others.
The singleplex immunoassay global market, by application, is segmented into research and development, clinical diagnostics, and others. The research and development are further segmented into drug discovery & development and biomarker discovery and validation. The clinical diagnostics are further segmented into infectious diseases, cancer, cardiovascular diseases, autoimmune diseases, nervous system disorders, and metabolism & endocrinology disorders.
On the basis of the end-user, the market is segmented as pharmaceutical & biotechnology companies, hospitals & research institutes, reference laboratories and others.
Geographically, the market has been segmented into America, Europe, Asia-Pacific, and the Middle East & Africa. The Americas singleplex immunoassay market is further segmented into North America, and South America. North America is further classified as the US and Canada.
The Europe market is segmented into Western Europe and Eastern Europe. Western Europe is further classified as Germany, France, the UKUK, Italy, Spain, and the Rest of Western Europe.
The Asia-Pacific market is segmented into Japan, China, India, Republic of Korea, Australia, and Rest of Asia-Pacific.
The Middle East & Africa market is segmented into the Middle East, and Africa.
The global singleplex immunoassay market consists of four regions: Americas, Europe, Asia-Pacific and the Middle East & Africa. The Americas is expected to dominate the singleplex immunoassay market owing to the presence of major market players, high adoption rate, and increasing prevalence of infectious diseases. According to the statistics suggested by the Centers for Disease Control (CDC) and Prevention, in 2014, around 9,421 cases of tuberculosis, 51,455 cases of salmonella, 33,461 cases of Lyme disease, and 433 cases of meningococcal disease were registered in the United States.
Europe is anticipated to hold the second position in the global singleplex immunoassay market. It is expected that the rising automation in an immunoassay, increasing prevalence of chronic diseases, funding provided by the government, and private organizations towards research & development are anticipated to drive the European market.
The Asia-Pacific singleplex immunoassay market consists of countries namely China, Japan, Republic of Korea, India, Australia and Rest of Asia-Pacific. Asia-Pacific is the fastest growing in singleplex immunoassay market. Major factors such as growing patient pool, high incidence of chronic diseases, developing healthcare infrastructure and increasing research & development activities in the biotechnology sector, increasing healthcare expenditure influences the market in this region. Additionally, according to the data suggested by the Australian Institute of Health and Welfare during the year 2015-16, the total health expenditure was USD 170.4 billion, i.e., 3.6 % higher than the expenditure of 2014-2015.
The Middle East and Africa hold the least share in the global singleplex immunoassay market due to the presence of stringent government policies and poor economies. However, growing awareness among the population and high investments by private market players in this region can boost the market growth.
Market Research Future research is conducted by industry experts who offer insight into industry structure, market segmentation, Treatment assessment, competitive landscape (CL), penetration, as well as on emerging trends. Besides primary interviews (~ 80%) and secondary research (~ 20%), their analysis is based on their years of professional expertise in respective industries. Our analysts also predict where the market will be headed in the next five to ten years, by analyzing historical trends and current market positions. Furthermore, the varying trends of segments & categories geographically presented are studied and are estimated based on primary & secondary research.
Intended Audience
| Report Attribute/Metric | Details |
| Market Size | 0.207 Billion |
| CAGR | 10.34% |
| Base Year | 2023 |
| Forecast Period | 2024-2032 |
| Historical Data | 2022 |
| Forecast Units | Value (USD Billion) |
| Report Coverage | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends |
| Segments Covered | Product And Service, Type, Technology, Application, And End-User |
| Geographies Covered | North America, Europe, Asia-Pacific, and Rest of the World (RoW) |
| Key Vendors | Luminex, Thermo Fisher Scientific, Illumina, Bio-Rad Laboratories, QIAGEN N.V, Abcam, Becton Dickinson and Company, Merck Life sciences, Agilent Technologies, Quanterix, Bio-Techne, Olink, Seegene, BioVendor |
| Key Market Opportunities | Government assistance |
| Key Market Drivers | Rising prevalence of chronic diseases and growing biotechnology sector |
Singleplex Immunoassay Market Highlights:
Frequently Asked Questions (FAQ) :
Singleplex Immunoassay Market is projected to grow at an 10.34% CAGR between 2024-2032.
The Americas is expected to lead the Singleplex Immunoassay Market.
Rising prevalence of chronic diseases and growing biotechnology sector is boosting market growth.
Poor healthcare system may limit market growth.
Different strategies used by market players to create a dominance in the Singleplex Immunoassay Market growth include mergers, collaborations, product developments, and R&D.
Leading companies partner with us for data-driven Insights.
Kindly complete the form below to receive a free sample of this Report
Research Analyst Level I He is an extremely curious individual currently working in healthcare and medical devices domain. kinjoll is comfortably versed in data centric research backed by healthcare educational background. he leverages extensive data mining and analytics tools such as primary and secondary research, statistical analysis, machine learning, data modelling. his key role also involves technical sales support, client interaction and project management within the healthcare team. lastly, he showcases extensive affinity towards learning new skills and remain fascinated in implementing them.
Get in Touch
© 2024 Market Research Future ® (Part of WantStats Reasearch And Media Pvt. Ltd.)
